検索タンパク質、抗体、アッセイキット
タンパク質カタログ
- サプライヤー
- AcroBioSystems
- カタログNo.
- HLG-H82E4
- 製品名称
- Biotinylated Human HLA-A*02:01&B2M&Glypican 3 (FVGEFFTDV) Complex Protein (Monomer, MALS verified)
- タンパク質名
- HLA-A*02:01 & B2M & Glypican 3
- Species
- Human
- HOST
- HEK293
Overview
| Synonyms | - |
|---|---|
| Characteristics | Biotinylated Human HLA-A*02:01&B2M&Glypican 3 (FVGEFFTDV) Complex Protein is produced by co-expression of HLA and B2M loaded with Glypican 3 peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag?). The protein has a calculated MW of 36.0 kDa and 13.8 kDa. The protein migrates as 42-45 kDa and 14 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
| Endotoxin Level | 1.0 EU per μg |
| Purity | 95% |
| Description | Glypican-3 (GPC3) is also known as Intestinal protein OCI-5, GTR2-2, MXR7, which belongs to the glypican family. Glypican 3 / GPC-3 is highly expressed in lung, liver and kidney. Glypican-3 inhibits the dipeptidyl peptidase activity of DPP4. Glypican-3 may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and also may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. The Human HLA-A*0201 Glycipan 3 (FVGEFFTDV) complex protein is a complex of HLA-A*0201 of?the MHC Class I, B2M and FVGEFFTDV peptide of?the Glycipan 3 . |
| Reference | - |
| URL | https://www.acrobiosystems.com/P5258-Biotinylated-Human-HLA-A%2A02%3A01B2MGlypican-3-%28FVGEFFTDV%29-Complex-Protein-%28Monomer-MALS-verified%29.html |
お問い合わせリスト